Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : dapsone
  • Active substance : clarithromycine
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Transfusions, transplantations (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Sexually transmitted diseases (1)
      • Virus diseases (1)
      • Parasitic diseases and mycoses (1)
    • Immune system diseases (1)
    • Plus ...
      • Immunologic deficiency syndromes (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Date
  • Last five years (1)
Manufacturer
  • inconnu (1)
Language
  • Français (1)
Active substance
  • acide folinique (1)
  • atovaquone (1)
  • clarithromycine (1)
  • clindamycine (1)
  • dapsone (1)
  • sulfadiazine (1)
  • sulfadoxine (1)

Drugs, devices and medical acts - 1 result

  • Laboratory diagnosis of toxoplasmosis in immunocompromised patients HIV-infected patients, haematopoietic stem cell transplant recipients and solid organ transplant recipients - INAHTA Brief

    Health technology assessment - Posted on 29/5/2017
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
aVba9240Cv2X50dp